
Chinese General Practice ›› 2024, Vol. 27 ›› Issue (26): 3304-3311.DOI: 10.12114/j.issn.1007-9572.2024.0043
Special Issue: 脑健康最新研究合辑
• Evidence-based Medicine • Previous Articles Next Articles
Received:2024-02-10
Revised:2024-04-10
Published:2024-09-15
Online:2024-06-14
Contact:
ZHAO Chunshan
通讯作者:
赵春善
作者简介:作者贡献:
韩雪梅提出文章选题,负责研究的构思与设计,论文撰写;梅春丽、陈丹进行数据的收集与整理,统计学处理,图、表的绘制与展示;赵春善负责文章的质量控制及审校,对文章整体负责、监督管理。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0043
| 步骤 | 检索式 |
|---|---|
| #1 | "Alcohols"[Mesh] |
| #2 | Ethanol OR Beer OR Wine OR Spirits OR Liquor OR drink |
| #3 | #1 OR #2 |
| #4 | "Stroke"[Mesh] |
| #5 | Cerebrovascular Accident OR Cerebrovascular Apoplexy OR Brain Vascular Accident OR Cerebrovascular Stroke OR Cerebral Infarction OR Transient Ischemic attack OR TIA |
| #6 | #4 OR #5 |
| #7 | #3 AND #6 |
Table 1 Strategy for searching eligible systematic reviews included in PubMed database
| 步骤 | 检索式 |
|---|---|
| #1 | "Alcohols"[Mesh] |
| #2 | Ethanol OR Beer OR Wine OR Spirits OR Liquor OR drink |
| #3 | #1 OR #2 |
| #4 | "Stroke"[Mesh] |
| #5 | Cerebrovascular Accident OR Cerebrovascular Apoplexy OR Brain Vascular Accident OR Cerebrovascular Stroke OR Cerebral Infarction OR Transient Ischemic attack OR TIA |
| #6 | #4 OR #5 |
| #7 | #3 AND #6 |
| 第一作者 | 发表年份(年) | 国家 | 随访年限(年) | 年龄(岁) | 性别 | 暴露人数/样本量 | 测量方法 | 摄入量范围(最低量/最高量) | 校正RR值(95%CI) | 校正因素 | NOS评分(分) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DONAHUE[ | 1986 | 美国 | 12.0 | 54.2 | 男 | 290/7 878 | 医疗记录 | 0/≥40盎司/月 | 1.50(1.10~2.20) | 因素1、因素2、因素3、尿酸、葡萄糖浓度、血红蛋白 | 8 |
| STAMPFER[ | 1988 | 美国 | 8.0 | 34~59 | 女 | 94/87 526 | 问卷调查 | 0/≥25 g/d | 0.90(0.50~1.50) | 因素1、因素2、糖尿病、绝经状态、激素使用情况、高胆固醇 | 9 |
| BERGER[ | 1999 | 美国 | 12.2 | 40~80 | 男 | 679/21 870 | 医疗记录 | <1 g/周/≥1 g/d | 0.90(0.74~1.09) | 因素1、因素2、糖尿病史 | 8 |
| LEPPALA[ | 1999 | 芬兰 | 6.1 | 50~69 | 男 | 960/26 556 | 问卷调查 | 0/>60 g/d | 1.52(1.12~2.08) | 因素1、因素2、高胆固醇血症、糖尿病、心血管病史 | 8 |
| ISO[ | 2004 | 日本 | 11.0 | 40~59 | 男 | 694/19 544 | 自我报告 | 0/≥450 g/周 | 1.43(1.05~1.96) | 因素1、因素2、糖尿病史、运动频率时间 | 8 |
| NIELSEN[ | 2005 | 丹麦 | 15.0 | >20 | 男/女 | 880/12 096 | 自我报告 | <1 g/周/>40 g/周 | 2.08(1.40~3.09) | 因素1、因素2、糖尿病、AMI病史 | 9 |
| BAZZANO[ | 2007 | 中国 | 8.0 | >40 | 男 | 3 434/64 338 | 自我报告 | 0/≥35 g/周 | 1.22(1.08~1.37) | 因素1、居住地区、糖尿病史 | 7 |
| LU[ | 2008 | 瑞典 | 11.4 | 30~50 | 女 | 170/45 449 | 自我报告 | 0/≥70 g/周 | 0.70(0.40~1.20) | 因素1、因素2、因素3、初产年龄 | 9 |
| BOS[ | 2010 | 欧洲 | 14.2 | 49~70 | 女 | 254/10 530 | 问卷调查 | 0/≥140 g/周 | 0.81(0.51~1.29) | 因素1、因素2、糖尿病、高胆固醇血症、绝经状态、每日能量摄入 | 9 |
| HIGASHIYAMA[ | 2011 | 日本 | 12.5 | 30~79 | 男 | 54/1 169 | 自我报告 | 0/≥4.0 g/周 | 0.70(0.29~1.69) | 因素1、因素2、糖尿病、高胆固醇血症、三酰甘油 | 8 |
| HIGASHIYAMA[ | 2011 | 日本 | 12.5 | 30~79 | 男 | 59/1 167 | 自我报告 | 0/≥4.0 g/周 | 4.68(1.07~20.54) | 因素1、因素2、糖尿病、高胆固醇血症、三酰甘油 | 8 |
| JIMENEZ[ | 2012 | 美国 | 26.0 | 30~55 | 女 | 2 171/83 578 | 自我报告 | 0/30~45 g/d | 1.06(0.86~1.30) | 因素1、婚姻状况、心脏病史、绝经状态、激素治疗、高胆固醇、糖尿病史 | 9 |
| IKEHARA[ | 2013 | 日本 | 16.7 | 40~69 | 女 | 1 846/47 100 | 医疗记录 | 0/≥300 g/周 | 2.30(1.52~3.49) | 因素1、因素2、糖尿病史、精神感知压力、蔬菜、鱼、水果摄入量 | 8 |
| FALKSTEDT[ | 2017 | 瑞典 | 39.0 | >18 | 男 | 1 037/49 321 | 医疗记录 | 0/>250 g/周 | 1.39(0.91~2.13) | 因素1、因素2、心血管病、家族史、糖尿病、偏头痛、心肺健康 | 7 |
| DEGERUD[ | 2021 | 挪威 | 9.1 | 19~89 | 男/女 | 547/44 476 | 医疗记录 | 2.00 g/d/59.99 g/d | 1.04(0.84~1.28) | 因素1、因素2、因素3、冠心病家族史 | 9 |
| LU[ | 2021 | 中国 | 27.0 | >18 | 男 | 352/3 906 | 医疗记录 | 0/≥36 g/d | 0.72(0.43~1.21) | 因素1、因素2、因素3 | 8 |
| LIU[ | 2023 | 中国 | 3.8 | 30~79 | 男/女 | 310/22 091 | 医疗记录 | 0/≥36 g/d | 1.34(0.82~2.19) | 因素1、因素2、糖尿病、低脂血症、蔬菜、水果、红肉摄入量 | 9 |
Table 2 Basic features of included studies
| 第一作者 | 发表年份(年) | 国家 | 随访年限(年) | 年龄(岁) | 性别 | 暴露人数/样本量 | 测量方法 | 摄入量范围(最低量/最高量) | 校正RR值(95%CI) | 校正因素 | NOS评分(分) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DONAHUE[ | 1986 | 美国 | 12.0 | 54.2 | 男 | 290/7 878 | 医疗记录 | 0/≥40盎司/月 | 1.50(1.10~2.20) | 因素1、因素2、因素3、尿酸、葡萄糖浓度、血红蛋白 | 8 |
| STAMPFER[ | 1988 | 美国 | 8.0 | 34~59 | 女 | 94/87 526 | 问卷调查 | 0/≥25 g/d | 0.90(0.50~1.50) | 因素1、因素2、糖尿病、绝经状态、激素使用情况、高胆固醇 | 9 |
| BERGER[ | 1999 | 美国 | 12.2 | 40~80 | 男 | 679/21 870 | 医疗记录 | <1 g/周/≥1 g/d | 0.90(0.74~1.09) | 因素1、因素2、糖尿病史 | 8 |
| LEPPALA[ | 1999 | 芬兰 | 6.1 | 50~69 | 男 | 960/26 556 | 问卷调查 | 0/>60 g/d | 1.52(1.12~2.08) | 因素1、因素2、高胆固醇血症、糖尿病、心血管病史 | 8 |
| ISO[ | 2004 | 日本 | 11.0 | 40~59 | 男 | 694/19 544 | 自我报告 | 0/≥450 g/周 | 1.43(1.05~1.96) | 因素1、因素2、糖尿病史、运动频率时间 | 8 |
| NIELSEN[ | 2005 | 丹麦 | 15.0 | >20 | 男/女 | 880/12 096 | 自我报告 | <1 g/周/>40 g/周 | 2.08(1.40~3.09) | 因素1、因素2、糖尿病、AMI病史 | 9 |
| BAZZANO[ | 2007 | 中国 | 8.0 | >40 | 男 | 3 434/64 338 | 自我报告 | 0/≥35 g/周 | 1.22(1.08~1.37) | 因素1、居住地区、糖尿病史 | 7 |
| LU[ | 2008 | 瑞典 | 11.4 | 30~50 | 女 | 170/45 449 | 自我报告 | 0/≥70 g/周 | 0.70(0.40~1.20) | 因素1、因素2、因素3、初产年龄 | 9 |
| BOS[ | 2010 | 欧洲 | 14.2 | 49~70 | 女 | 254/10 530 | 问卷调查 | 0/≥140 g/周 | 0.81(0.51~1.29) | 因素1、因素2、糖尿病、高胆固醇血症、绝经状态、每日能量摄入 | 9 |
| HIGASHIYAMA[ | 2011 | 日本 | 12.5 | 30~79 | 男 | 54/1 169 | 自我报告 | 0/≥4.0 g/周 | 0.70(0.29~1.69) | 因素1、因素2、糖尿病、高胆固醇血症、三酰甘油 | 8 |
| HIGASHIYAMA[ | 2011 | 日本 | 12.5 | 30~79 | 男 | 59/1 167 | 自我报告 | 0/≥4.0 g/周 | 4.68(1.07~20.54) | 因素1、因素2、糖尿病、高胆固醇血症、三酰甘油 | 8 |
| JIMENEZ[ | 2012 | 美国 | 26.0 | 30~55 | 女 | 2 171/83 578 | 自我报告 | 0/30~45 g/d | 1.06(0.86~1.30) | 因素1、婚姻状况、心脏病史、绝经状态、激素治疗、高胆固醇、糖尿病史 | 9 |
| IKEHARA[ | 2013 | 日本 | 16.7 | 40~69 | 女 | 1 846/47 100 | 医疗记录 | 0/≥300 g/周 | 2.30(1.52~3.49) | 因素1、因素2、糖尿病史、精神感知压力、蔬菜、鱼、水果摄入量 | 8 |
| FALKSTEDT[ | 2017 | 瑞典 | 39.0 | >18 | 男 | 1 037/49 321 | 医疗记录 | 0/>250 g/周 | 1.39(0.91~2.13) | 因素1、因素2、心血管病、家族史、糖尿病、偏头痛、心肺健康 | 7 |
| DEGERUD[ | 2021 | 挪威 | 9.1 | 19~89 | 男/女 | 547/44 476 | 医疗记录 | 2.00 g/d/59.99 g/d | 1.04(0.84~1.28) | 因素1、因素2、因素3、冠心病家族史 | 9 |
| LU[ | 2021 | 中国 | 27.0 | >18 | 男 | 352/3 906 | 医疗记录 | 0/≥36 g/d | 0.72(0.43~1.21) | 因素1、因素2、因素3 | 8 |
| LIU[ | 2023 | 中国 | 3.8 | 30~79 | 男/女 | 310/22 091 | 医疗记录 | 0/≥36 g/d | 1.34(0.82~2.19) | 因素1、因素2、糖尿病、低脂血症、蔬菜、水果、红肉摄入量 | 9 |
| [1] |
王陇德,彭斌,张鸿祺,等. 《中国脑卒中防治报告2020》概要[J]. 中国脑血管病杂志,2022,19(2):136-144.
|
| [2] |
|
| [3] |
|
| [4] |
江滨. 现阶段我国脑卒中流行特征及防治现状对全科医疗服务的启示和建议[J]. 中国全科医学,2019,22(30):3653-3661. DOI:10.12114/j.issn.1007-9572.2019.00.445.
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
罗美玲,林希建,刘如春,等. 剂量反应关系Meta分析在Stata软件中的实现[J]. 循证医学,2014,14(3):182-187. DOI:10.3969/j.issn.1671-5144.2014.03.012.
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国脑血管病一级预防指南2019[J]. 中华神经科杂志,2019,52(9):684-709. DOI:10.3760/cma.j.issn.1006-7876.2019.09.002.
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [1] | GE Dan, WANG Zhi, DING Qun, GUO Tonglan, XU Tongdao. Relationship between Remnant Cholesterol and Non-alcoholic Fatty Liver Disease as well as Progressive Liver Fibrosis in Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(20): 2854-2859. |
| [2] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [3] | LIU Ying, LIU Shiwei, ZHANG Chi, SHEN Ji, ZHANG Yushan, ZHANG Jie, SANG Yingchen, WANG Youjiao, WANG Lei, ZHOU Houguang, SHI Hong. Prevalence and Associated Factors of Subjective Cognitive Decline among Older Stroke Patients in China [J]. Chinese General Practice, 2026, 29(20): 2829-2835. |
| [4] | LI Yutong, ZHAO Danting, JIANG Feng, WANG Yanna, LIU Yizong, LIANG Wenjuan, LU Jiahai. Systematic Review and Meta-analysis of the Efficacy and Safety of mRNA and Recombinant Protein Subunit Vaccines Against Respiratory Syncytial Virus [J]. Chinese General Practice, 2026, 29(19): 2744-2752. |
| [5] | ZHANG Wenbo, WANG Junlong, ZHANG Yuping, JIANG Shuai, WANG Huaqi. The Risk of Pre-COPD Populations Progressing to COPD under Different Criteria: a Meta-analysis [J]. Chinese General Practice, 2026, 29(19): 2735-2743. |
| [6] | HUANG Minshan, CHEN Hang, LI Liya, YANG Taiming, CHEN Lifang, LI Shenchao, REN Li, WANG Hui, LI Mingke, WANG Xianmei, WANG Da, WAN Ying, HE Yule, ZHOU Qingqing, LI Yu, LI Mengwei, LU Lihong, LUO Yifan, MA Lanqing. The Current Status of Awareness and Influencing Factors Analysis of Metabolic-associated Fatty Liver Disease among the General Population in Multiple Regions of Yunnan [J]. Chinese General Practice, 2026, 29(17): 2347-2353. |
| [7] | WU Ruining, ZHOU Ming, ZHANG Gongzi, LI Jun, XIE Suhang, LIU Yangxiaoxue, ZHANG Jiali, LIU Maomao, HUANG Liping. Study on Fixed and Mobile Exoskeleton Robots in Improving Lower Limb Function and Quality of Life in Stroke Patients: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(17): 2326-2333. |
| [8] | YU Chao, SONG Lihua, WANG Linyan, LU Yunping, WANG Linyang, CUI Wei. The Functional Outcomes and Influencing Factors in Patients with First-episode Major Depressive Disorder after 7 Years [J]. Chinese General Practice, 2026, 29(16): 2221-2226. |
| [9] | JI Ying, GUO Chuan, ZHU Shizhe, JI Panpan, WANG Tong, KAN Chaojie, WANG Qinglei. Effects of Intermittent Theta Burst Stimulation of the Cerebellum on Different Balance Abilities in Patients with Supratentorial Stroke: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(15): 2022-2028. |
| [10] | TIAN Anni, YANG Jing, SUN Jing, WANG Shichun. Effect of Robot-assisted Training on the Recovery of Hand Motor Function in Patients with Different Stages of Stroke: a Meta-analysis [J]. Chinese General Practice, 2026, 29(14): 1911-1920. |
| [11] | ZHAN Li, HENG Zhaoyang, HE Liangyu, ZHAO Jie, CHEN Jie, XING Jinshan. Efficacy and Safety of CAR-T Therapy Targeting the B Cell Maturation Antigen on Relapsed/Refractory Multiple Myeloma in Chinese People: a Meta-analysis [J]. Chinese General Practice, 2026, 29(14): 1921-1930. |
| [12] | HAN Yue, BIAN Zhe, GU Haochen, WANG Dali, PENG Yanbo. Impact of Cumulative Defined Daily Dose of Statins on Recurrence Risk in Ischemic Stroke Patients [J]. Chinese General Practice, 2026, 29(14): 1821-1826. |
| [13] | LIU Yang, LIANG Fang, WU Ling, LI Wenlei, LI Pengfei. Diagnostic Value of Non-conventional Lipids and the Triglyceride-glucose Index in First-onset Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(11): 1422-1429. |
| [14] | WANG Fei, HAN Weiyu, SUN Tao. Moxibustion Combined with Three-step Therapy in the Treatment of Cancer Pain: a Network Meta-analysis [J]. Chinese General Practice, 2026, 29(09): 1203-1211. |
| [15] | WANG Xiaonan, RUAN Xiaonan, LIU Yang, WU Kang, QIU Hua, LIU Qingping, SONG Jiahui, GAO Jiaojiao, ZHOU Yi, LIU Xiaolin. Correlation between Anthropometric Indices and the Risk of Stroke: a Nested Case-control Study [J]. Chinese General Practice, 2026, 29(08): 1020-1028. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||